Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Iovance Biotherapeutics Inc. (IOVA)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Broadfin Capital

Kevin Kotler

4,894,361 $55,062 +19% 8.1%
2.
Great Point Partners

Jeffrey Jay And David Kroin

3,496,340 $39,334 +1% 6.12%
3. 2,188,331 $24,619 4.5%
4.
Prosight Capital

Lawrence Hawkins

715,317 $8,047 +63% 4.48%
5.
VenBio Select Advisor

Kurt Von Emster

8,662,720 $97,456 +6% 4.47%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$9.86 300,000 Director 7,067,333 2018-12-06 Filing
$10.31 921,053 Director 6,767,333 2018-12-04 Filing
$2.00 50,000 Director 396,432 2013-11-05 Filing
$2.00 125,000 Large Shareholder, Officer, Director 1,938,500 2013-11-05 Filing
$0.22 10,000 Large Shareholder 10,023,628 2012-12-31 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$8.71 20,500 Director 100,000 2016-08-25 Filing
$9.10 33,500 Director 120,500 2016-08-24 Filing
$9.11 54,000 Director 100,000 2016-08-22 Filing
$7.13 16,500 Director 154,000 2015-09-08 Filing
$6.84 16,000 Director 170,500 2015-09-04 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 2,222,701 $25,005 8.91%
2. 1,290,495 $14,518 1.45%
3. 185,915 $2,092 1.36%
4. 700,000 $7,875 0.2%
5. 124,854 $1,405 0.18%
News See All